ENTITY
CSL Ltd

CSL Ltd (CSL AU)

111
Analysis
Health CareAustralia
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
Refresh
21 Mar 2018 18:07

Aussie Equities Model Portfolio Update

Australia is in a sweet spot. We are sticking to the themes and sector positioning outlined in our 2018 outlook.  We still think the ASX200 will...

Logo
110 Views
Share
bullishSanofi
23 Jan 2018 00:41

Sanofi: Stop the Bleeding with Bioverativ

Today, Sanofi (SAN FP) announced that it is acquiring Bioverativ Inc (BIVV US) for $11.6 billion (a 64% premium).  Management hosted a conference...

Logo
261 Views
Share
13 Dec 2017 17:44

Aussie Healthcare Daily: 12 & 13 Dec 2017

The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...

Logo
407 Views
Share
12 Dec 2017 12:43

Putting Aussie Earnings Under the Microscope

It's not too late to jump on board the Growth train. One of our key calls for 2018 is that Growth will again outperform Value (Aussie Equities...

Logo
124 Views
Share
05 Dec 2017 14:26

Aussie Healthcare Daily: 5 Dec 2017

The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...

Logo
146 Views
Share
x